![]() |
**__Related stories:__***linkurl:Give Young Scientists a Break;http://www.the-scientist.com/article/display/56081/
[November 2009]*linkurl:NIH R01s: No Longer the Best Science;http://www.the-scientist.com/article/display/55930/
[September 2009]
The new, shortened National Institutes of Health grant applications, designed to make the process easier on applicants and reviewers, may have an unintended downside, some researchers say. Specifically, some critics say the new, shorter forms -- down from 25 to 12 pages for R01 grants -- will favor better writers, making it more difficult for younger investigators to compete for NIH funding. "[The new grant applications] are going to focus people's words, and I do think it will favor better wr
![]() |


From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile
These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".
View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.


In our next roundtable webinar, learn how scientists leverage spatial biology to map tissues, uncover cellular interactions, and advance disease research.

Discover how scientists use the latest gene editing tools to advance health research.


Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and high diagnostic performance.


Ten-year Agreement to Provide a Secure, AI-enabled Forensic Laboratory Information Management System Supporting DHS Forensic, Scientific, and Testing Services

deliver robust, reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics

Enables higher-throughput, cost effective single-cell sequencing

Enables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDs